Medical Care
Global Respiratory Distress Syndrome Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jul 08, 25
- ID: 353266
- Pages: 121
- Figures: 119
- Views: 12
In 2024, the global market size of Respiratory Distress Syndrome was estimated to be worth US$ 420 million and is forecast to reach approximately US$ 608 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.
North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Respiratory Distress Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Distress Syndrome.
The Respiratory Distress Syndrome market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Respiratory Distress Syndrome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Distress Syndrome companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Segment by Type
Poractant Alfa
Beractant
Calfactant
Others
Segment by Application
Very Preterm Infants
Moderate to Late Preterm Infants
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Respiratory Distress Syndrome in global and regional level.
Chapter 3: Detailed analysis of Respiratory Distress Syndrome company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Respiratory Distress Syndrome revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.
North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Respiratory Distress Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Distress Syndrome.
The Respiratory Distress Syndrome market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Respiratory Distress Syndrome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Distress Syndrome companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Segment by Type
Poractant Alfa
Beractant
Calfactant
Others
Segment by Application
Very Preterm Infants
Moderate to Late Preterm Infants
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Respiratory Distress Syndrome in global and regional level.
Chapter 3: Detailed analysis of Respiratory Distress Syndrome company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Respiratory Distress Syndrome revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Respiratory Distress Syndrome Product Introduction
1.2 Market by Type
1.2.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Poractant Alfa
1.2.3 Beractant
1.2.4 Calfactant
1.2.5 Others
1.3 Market by Application
1.3.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Very Preterm Infants
1.3.3 Moderate to Late Preterm Infants
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Respiratory Distress Syndrome Market Size Estimates and Forecasts
2.2 Respiratory Distress Syndrome Market Size by Region: 2024 Versus 2031
2.2.1 Global Respiratory Distress Syndrome Revenue by Region: 2020-2025
2.2.2 Global Respiratory Distress Syndrome Revenue Forecast by Region (2026-2031)
2.2.3 Global Respiratory Distress Syndrome Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Respiratory Distress Syndrome Revenue by Type (2020-2031)
3.1.2 Global Respiratory Distress Syndrome Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Respiratory Distress Syndrome Revenue by Application (2020-2031)
3.2.2 Global Respiratory Distress Syndrome Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Poractant Alfa of Respiratory Distress Syndrome Revenue Market Share by Application
3.3.2 Beractant of Respiratory Distress Syndrome Revenue Market Share by Application
3.3.3 Calfactant of Respiratory Distress Syndrome Revenue Market Share by Application
3.3.4 Others of Respiratory Distress Syndrome Revenue Market Share by Application
4 Global Respiratory Distress Syndrome by Company
4.1 Global Respiratory Distress Syndrome Revenue by Company (2020-2025)
4.2 Global Respiratory Distress Syndrome Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Respiratory Distress Syndrome Companies around the World: Ranking by Revenue
4.3.2 Global Respiratory Distress Syndrome Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Respiratory Distress Syndrome Companies Headquarters & Product Type
4.4.1 Global Respiratory Distress Syndrome Companies Headquarters
4.4.2 Date of International Companies Enter into Respiratory Distress Syndrome Market
4.4.3 Global Respiratory Distress Syndrome Companies Product & Service
4.4.4 Poractant Alfa Revenue Market Share of Respiratory Distress Syndrome by Company
4.4.5 Beractant Revenue Market Share of Respiratory Distress Syndrome by Company
4.4.6 Calfactant Revenue Market Share of Respiratory Distress Syndrome by Company
4.4.7 Others Revenue Market Share of Respiratory Distress Syndrome by Company
4.5 Global Respiratory Distress Syndrome Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Chiesi Farmaceutici
5.1.1 Chiesi Farmaceutici Corporation Information
5.1.2 Chiesi Farmaceutici Description, Business Overview
5.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Products Offered
5.1.4 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.1.5 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue by Product in 2024
5.1.6 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue by Application in 2024
5.1.7 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.1.8 Chiesi Farmaceutici Recent Developments
5.2 CR-Double Crane
5.2.1 CR-Double Crane Corporation Information
5.2.2 CR-Double Crane Description, Business Overview
5.2.3 CR-Double Crane Respiratory Distress Syndrome Products Offered
5.2.4 CR-Double Crane Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.2.5 CR-Double Crane Respiratory Distress Syndrome Revenue by Product in 2024
5.2.6 CR-Double Crane Respiratory Distress Syndrome Revenue by Application in 2024
5.2.7 CR-Double Crane Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.2.8 CR-Double Crane Recent Developments
5.3 ONY Biotech
5.3.1 ONY Biotech Corporation Information
5.3.2 ONY Biotech Description, Business Overview
5.3.3 ONY Biotech Respiratory Distress Syndrome Products Offered
5.3.4 ONY Biotech Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.3.5 ONY Biotech Respiratory Distress Syndrome Revenue by Product in 2024
5.3.6 ONY Biotech Respiratory Distress Syndrome Revenue by Application in 2024
5.3.7 ONY Biotech Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.3.8 ONY Biotech Recent Developments
5.4 AbbVie
5.4.1 AbbVie Corporation Information
5.4.2 AbbVie Description, Business Overview
5.4.3 AbbVie Respiratory Distress Syndrome Products Offered
5.4.4 AbbVie Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.4.5 AbbVie Respiratory Distress Syndrome Revenue by Product in 2024
5.4.6 AbbVie Respiratory Distress Syndrome Revenue by Application in 2024
5.4.7 AbbVie Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.4.8 AbbVie Recent Developments
5.5 Yuhan Corporation
5.5.1 Yuhan Corporation Corporation Information
5.5.2 Yuhan Corporation Description, Business Overview
5.5.3 Yuhan Corporation Respiratory Distress Syndrome Products Offered
5.5.4 Yuhan Corporation Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.5.5 Yuhan Corporation Respiratory Distress Syndrome Revenue by Product in 2024
5.5.6 Yuhan Corporation Respiratory Distress Syndrome Revenue by Application in 2024
5.5.7 Yuhan Corporation Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.5.8 Yuhan Corporation Recent Developments
5.6 JW Pharmaceuticals
5.6.1 JW Pharmaceuticals Corporation Information
5.6.2 JW Pharmaceuticals Description, Business Overview
5.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Products Offered
5.6.4 JW Pharmaceuticals Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.6.5 JW Pharmaceuticals Respiratory Distress Syndrome Revenue by Product in 2024
5.6.6 JW Pharmaceuticals Respiratory Distress Syndrome Revenue by Application in 2024
5.6.7 JW Pharmaceuticals Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.6.8 JW Pharmaceuticals Recent Developments
5.7 Noargen
5.7.1 Noargen Corporation Information
5.7.2 Noargen Description, Business Overview
5.7.3 Noargen Respiratory Distress Syndrome Products Offered
5.7.4 Noargen Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.7.5 Noargen Respiratory Distress Syndrome Revenue by Product in 2024
5.7.6 Noargen Respiratory Distress Syndrome Revenue by Application in 2024
5.7.7 Noargen Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.7.8 Noargen Recent Developments
6 North America
6.1 North America Respiratory Distress Syndrome Market Size YoY Growth 2020-2031
6.2 North America Respiratory Distress Syndrome Market Facts & Figures by Country (2020-2031)
6.3 North America Respiratory Distress Syndrome Revenue by Type (2020-2025)
6.4 North America Respiratory Distress Syndrome Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Respiratory Distress Syndrome Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Respiratory Distress Syndrome Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Respiratory Distress Syndrome Revenue by Type (2020-2025)
7.4 Asia-Pacific Respiratory Distress Syndrome Revenue by Application (2020-2025)
8 Europe
8.1 Europe Respiratory Distress Syndrome Market Size YoY Growth 2020-2031
8.2 Europe Respiratory Distress Syndrome Market Facts & Figures by Country (2020-2031)
8.3 Europe Respiratory Distress Syndrome Revenue by Type (2020-2025)
8.4 Europe Respiratory Distress Syndrome Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Respiratory Distress Syndrome Market Size YoY Growth 2020-2031
9.2 Latin America Respiratory Distress Syndrome Market Facts & Figures by Country (2020-2031)
9.3 Latin America Respiratory Distress Syndrome Revenue by Type (2020-2025)
9.4 Latin America Respiratory Distress Syndrome Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Respiratory Distress Syndrome Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Respiratory Distress Syndrome Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Respiratory Distress Syndrome Revenue by Type (2020-2025)
10.4 Middle East and Africa Respiratory Distress Syndrome Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Respiratory Distress Syndrome Supply Chain Analysis
11.2 Respiratory Distress Syndrome Key Raw Materials and Upstream Suppliers
11.3 Respiratory Distress Syndrome Clients Analysis
11.4 Respiratory Distress Syndrome Sales Channel and Sales Model Analysis
11.4.1 Respiratory Distress Syndrome Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Respiratory Distress Syndrome Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Respiratory Distress Syndrome Distributors
12 Respiratory Distress Syndrome Market Dynamics
12.1 Respiratory Distress Syndrome Industry Trends
12.2 Respiratory Distress Syndrome Market Drivers
12.3 Respiratory Distress Syndrome Market Challenges
12.4 Respiratory Distress Syndrome Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Respiratory Distress Syndrome Product Introduction
1.2 Market by Type
1.2.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Poractant Alfa
1.2.3 Beractant
1.2.4 Calfactant
1.2.5 Others
1.3 Market by Application
1.3.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Very Preterm Infants
1.3.3 Moderate to Late Preterm Infants
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Respiratory Distress Syndrome Market Size Estimates and Forecasts
2.2 Respiratory Distress Syndrome Market Size by Region: 2024 Versus 2031
2.2.1 Global Respiratory Distress Syndrome Revenue by Region: 2020-2025
2.2.2 Global Respiratory Distress Syndrome Revenue Forecast by Region (2026-2031)
2.2.3 Global Respiratory Distress Syndrome Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Respiratory Distress Syndrome Revenue by Type (2020-2031)
3.1.2 Global Respiratory Distress Syndrome Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Respiratory Distress Syndrome Revenue by Application (2020-2031)
3.2.2 Global Respiratory Distress Syndrome Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Poractant Alfa of Respiratory Distress Syndrome Revenue Market Share by Application
3.3.2 Beractant of Respiratory Distress Syndrome Revenue Market Share by Application
3.3.3 Calfactant of Respiratory Distress Syndrome Revenue Market Share by Application
3.3.4 Others of Respiratory Distress Syndrome Revenue Market Share by Application
4 Global Respiratory Distress Syndrome by Company
4.1 Global Respiratory Distress Syndrome Revenue by Company (2020-2025)
4.2 Global Respiratory Distress Syndrome Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Respiratory Distress Syndrome Companies around the World: Ranking by Revenue
4.3.2 Global Respiratory Distress Syndrome Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Respiratory Distress Syndrome Companies Headquarters & Product Type
4.4.1 Global Respiratory Distress Syndrome Companies Headquarters
4.4.2 Date of International Companies Enter into Respiratory Distress Syndrome Market
4.4.3 Global Respiratory Distress Syndrome Companies Product & Service
4.4.4 Poractant Alfa Revenue Market Share of Respiratory Distress Syndrome by Company
4.4.5 Beractant Revenue Market Share of Respiratory Distress Syndrome by Company
4.4.6 Calfactant Revenue Market Share of Respiratory Distress Syndrome by Company
4.4.7 Others Revenue Market Share of Respiratory Distress Syndrome by Company
4.5 Global Respiratory Distress Syndrome Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Chiesi Farmaceutici
5.1.1 Chiesi Farmaceutici Corporation Information
5.1.2 Chiesi Farmaceutici Description, Business Overview
5.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Products Offered
5.1.4 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.1.5 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue by Product in 2024
5.1.6 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue by Application in 2024
5.1.7 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.1.8 Chiesi Farmaceutici Recent Developments
5.2 CR-Double Crane
5.2.1 CR-Double Crane Corporation Information
5.2.2 CR-Double Crane Description, Business Overview
5.2.3 CR-Double Crane Respiratory Distress Syndrome Products Offered
5.2.4 CR-Double Crane Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.2.5 CR-Double Crane Respiratory Distress Syndrome Revenue by Product in 2024
5.2.6 CR-Double Crane Respiratory Distress Syndrome Revenue by Application in 2024
5.2.7 CR-Double Crane Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.2.8 CR-Double Crane Recent Developments
5.3 ONY Biotech
5.3.1 ONY Biotech Corporation Information
5.3.2 ONY Biotech Description, Business Overview
5.3.3 ONY Biotech Respiratory Distress Syndrome Products Offered
5.3.4 ONY Biotech Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.3.5 ONY Biotech Respiratory Distress Syndrome Revenue by Product in 2024
5.3.6 ONY Biotech Respiratory Distress Syndrome Revenue by Application in 2024
5.3.7 ONY Biotech Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.3.8 ONY Biotech Recent Developments
5.4 AbbVie
5.4.1 AbbVie Corporation Information
5.4.2 AbbVie Description, Business Overview
5.4.3 AbbVie Respiratory Distress Syndrome Products Offered
5.4.4 AbbVie Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.4.5 AbbVie Respiratory Distress Syndrome Revenue by Product in 2024
5.4.6 AbbVie Respiratory Distress Syndrome Revenue by Application in 2024
5.4.7 AbbVie Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.4.8 AbbVie Recent Developments
5.5 Yuhan Corporation
5.5.1 Yuhan Corporation Corporation Information
5.5.2 Yuhan Corporation Description, Business Overview
5.5.3 Yuhan Corporation Respiratory Distress Syndrome Products Offered
5.5.4 Yuhan Corporation Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.5.5 Yuhan Corporation Respiratory Distress Syndrome Revenue by Product in 2024
5.5.6 Yuhan Corporation Respiratory Distress Syndrome Revenue by Application in 2024
5.5.7 Yuhan Corporation Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.5.8 Yuhan Corporation Recent Developments
5.6 JW Pharmaceuticals
5.6.1 JW Pharmaceuticals Corporation Information
5.6.2 JW Pharmaceuticals Description, Business Overview
5.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Products Offered
5.6.4 JW Pharmaceuticals Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.6.5 JW Pharmaceuticals Respiratory Distress Syndrome Revenue by Product in 2024
5.6.6 JW Pharmaceuticals Respiratory Distress Syndrome Revenue by Application in 2024
5.6.7 JW Pharmaceuticals Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.6.8 JW Pharmaceuticals Recent Developments
5.7 Noargen
5.7.1 Noargen Corporation Information
5.7.2 Noargen Description, Business Overview
5.7.3 Noargen Respiratory Distress Syndrome Products Offered
5.7.4 Noargen Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.7.5 Noargen Respiratory Distress Syndrome Revenue by Product in 2024
5.7.6 Noargen Respiratory Distress Syndrome Revenue by Application in 2024
5.7.7 Noargen Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.7.8 Noargen Recent Developments
6 North America
6.1 North America Respiratory Distress Syndrome Market Size YoY Growth 2020-2031
6.2 North America Respiratory Distress Syndrome Market Facts & Figures by Country (2020-2031)
6.3 North America Respiratory Distress Syndrome Revenue by Type (2020-2025)
6.4 North America Respiratory Distress Syndrome Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Respiratory Distress Syndrome Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Respiratory Distress Syndrome Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Respiratory Distress Syndrome Revenue by Type (2020-2025)
7.4 Asia-Pacific Respiratory Distress Syndrome Revenue by Application (2020-2025)
8 Europe
8.1 Europe Respiratory Distress Syndrome Market Size YoY Growth 2020-2031
8.2 Europe Respiratory Distress Syndrome Market Facts & Figures by Country (2020-2031)
8.3 Europe Respiratory Distress Syndrome Revenue by Type (2020-2025)
8.4 Europe Respiratory Distress Syndrome Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Respiratory Distress Syndrome Market Size YoY Growth 2020-2031
9.2 Latin America Respiratory Distress Syndrome Market Facts & Figures by Country (2020-2031)
9.3 Latin America Respiratory Distress Syndrome Revenue by Type (2020-2025)
9.4 Latin America Respiratory Distress Syndrome Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Respiratory Distress Syndrome Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Respiratory Distress Syndrome Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Respiratory Distress Syndrome Revenue by Type (2020-2025)
10.4 Middle East and Africa Respiratory Distress Syndrome Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Respiratory Distress Syndrome Supply Chain Analysis
11.2 Respiratory Distress Syndrome Key Raw Materials and Upstream Suppliers
11.3 Respiratory Distress Syndrome Clients Analysis
11.4 Respiratory Distress Syndrome Sales Channel and Sales Model Analysis
11.4.1 Respiratory Distress Syndrome Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Respiratory Distress Syndrome Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Respiratory Distress Syndrome Distributors
12 Respiratory Distress Syndrome Market Dynamics
12.1 Respiratory Distress Syndrome Industry Trends
12.2 Respiratory Distress Syndrome Market Drivers
12.3 Respiratory Distress Syndrome Market Challenges
12.4 Respiratory Distress Syndrome Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Respiratory Distress Syndrome Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Respiratory Distress Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Respiratory Distress Syndrome Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Respiratory Distress Syndrome Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Respiratory Distress Syndrome Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Respiratory Distress Syndrome Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Respiratory Distress Syndrome Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Respiratory Distress Syndrome Revenue by Company (2020-2025) & (US$ Million)
Table 11. Respiratory Distress Syndrome Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Respiratory Distress Syndrome Players by Revenue (US$ Million) in 2024
Table 13. Global Respiratory Distress Syndrome Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Respiratory Distress Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Distress Syndrome as of 2024)
Table 15. Global Respiratory Distress Syndrome Companies Headquarters
Table 16. Date of International Companies Enter into Respiratory Distress Syndrome Market
Table 17. Global Respiratory Distress Syndrome Companies Product & Service
Table 18. Global Respiratory Distress Syndrome Mergers & Acquisitions, Expansion Plans
Table 19. Chiesi Farmaceutici Corporation Information
Table 20. Chiesi Farmaceutici Description and Business Overview
Table 21. Chiesi Farmaceutici Respiratory Distress Syndrome Product
Table 22. Chiesi Farmaceutici Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Chiesi Farmaceutici Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
Table 24. Chiesi Farmaceutici Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
Table 25. Chiesi Farmaceutici Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
Table 26. Chiesi Farmaceutici Recent Developments
Table 27. CR-Double Crane Corporation Information
Table 28. CR-Double Crane Description and Business Overview
Table 29. CR-Double Crane Respiratory Distress Syndrome Product
Table 30. CR-Double Crane Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. CR-Double Crane Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
Table 32. CR-Double Crane Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
Table 33. CR-Double Crane Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
Table 34. CR-Double Crane Recent Developments
Table 35. ONY Biotech Corporation Information
Table 36. ONY Biotech Description and Business Overview
Table 37. ONY Biotech Respiratory Distress Syndrome Product
Table 38. ONY Biotech Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. ONY Biotech Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
Table 40. ONY Biotech Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
Table 41. ONY Biotech Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
Table 42. ONY Biotech Recent Developments
Table 43. AbbVie Corporation Information
Table 44. AbbVie Description and Business Overview
Table 45. AbbVie Respiratory Distress Syndrome Product
Table 46. AbbVie Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. AbbVie Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
Table 48. AbbVie Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
Table 49. AbbVie Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
Table 50. AbbVie Recent Developments
Table 51. Yuhan Corporation Corporation Information
Table 52. Yuhan Corporation Description and Business Overview
Table 53. Yuhan Corporation Respiratory Distress Syndrome Product
Table 54. Yuhan Corporation Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Yuhan Corporation Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
Table 56. Yuhan Corporation Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
Table 57. Yuhan Corporation Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
Table 58. Yuhan Corporation Recent Developments
Table 59. JW Pharmaceuticals Corporation Information
Table 60. JW Pharmaceuticals Description and Business Overview
Table 61. JW Pharmaceuticals Respiratory Distress Syndrome Product
Table 62. JW Pharmaceuticals Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. JW Pharmaceuticals Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
Table 64. JW Pharmaceuticals Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
Table 65. JW Pharmaceuticals Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
Table 66. JW Pharmaceuticals Recent Developments
Table 67. Noargen Corporation Information
Table 68. Noargen Description and Business Overview
Table 69. Noargen Respiratory Distress Syndrome Product
Table 70. Noargen Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Noargen Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
Table 72. Noargen Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
Table 73. Noargen Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
Table 74. Noargen Recent Developments
Table 75. North America Respiratory Distress Syndrome Revenue by Country (2020-2025) & (US$ Million)
Table 76. North America Respiratory Distress Syndrome Revenue by Country (2026-2031) & (US$ Million)
Table 77. North America Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
Table 78. North America Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
Table 79. Asia-Pacific Respiratory Distress Syndrome Revenue by Region (2020-2025) & (US$ Million)
Table 80. Asia-Pacific Respiratory Distress Syndrome Revenue by Region (2026-2031) & (US$ Million)
Table 81. Asia-Pacific Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
Table 82. Asia-Pacific Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
Table 83. Europe Respiratory Distress Syndrome Revenue by Country (2020-2025) & (US$ Million)
Table 84. Europe Respiratory Distress Syndrome Revenue by Country (2026-2031) & (US$ Million)
Table 85. Europe Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
Table 86. Europe Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
Table 87. Latin America Respiratory Distress Syndrome Revenue by Country (2020-2025) & (US$ Million)
Table 88. Latin America Respiratory Distress Syndrome Revenue by Country (2026-2031) & (US$ Million)
Table 89. Latin America Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
Table 90. Latin America Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
Table 91. Middle East and Africa Respiratory Distress Syndrome Revenue by Country (2020-2025) & (US$ Million)
Table 92. Middle East and Africa Respiratory Distress Syndrome Revenue by Country (2026-2031) & (US$ Million)
Table 93. Middle East and Africa Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
Table 94. Middle East and Africa Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
Table 95. Respiratory Distress Syndrome Key Raw Materials, Industry Status and Trend
Table 96. Respiratory Distress Syndrome Key Raw Materials and Upstream Suppliers
Table 97. Respiratory Distress Syndrome Clients Status and Trend
Table 98. Respiratory Distress Syndrome Typical Clients
Table 99. Respiratory Distress Syndrome Distributors
Table 100. Respiratory Distress Syndrome Market Trends
Table 101. Respiratory Distress Syndrome Market Drivers
Table 102. Respiratory Distress Syndrome Market Challenges
Table 103. Respiratory Distress Syndrome Market Restraints
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Respiratory Distress Syndrome Product Picture
Figure 2. Global Respiratory Distress Syndrome Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Respiratory Distress Syndrome Revenue Market Share by Type in 2024 & 2031
Figure 4. Poractant Alfa Product Picture
Figure 5. Beractant Product Picture
Figure 6. Calfactant Product Picture
Figure 7. Others Product Picture
Figure 8. Global Respiratory Distress Syndrome Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Respiratory Distress Syndrome Revenue Market Share by Application in 2024 & 2031
Figure 10. Very Preterm Infants
Figure 11. Moderate to Late Preterm Infants
Figure 12. Others
Figure 13. Respiratory Distress Syndrome Report Years Considered
Figure 14. Global Respiratory Distress Syndrome Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Respiratory Distress Syndrome Market Size (2020-2031) & (US$ Million)
Figure 16. Global Respiratory Distress Syndrome Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Respiratory Distress Syndrome Revenue Market Share by Region (2020-2031)
Figure 18. Global Respiratory Distress Syndrome Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Respiratory Distress Syndrome Revenue Market Share Forecast by Application (2020-2031)
Figure 20. Poractant Alfa of Respiratory Distress Syndrome Revenue Market Share by Application, 2024 VS 2031
Figure 21. Beractant of Respiratory Distress Syndrome Revenue Market Share by Application, 2024 VS 2031
Figure 22. Calfactant of Respiratory Distress Syndrome Revenue Market Share by Application, 2024 VS 2031
Figure 23. Others of Respiratory Distress Syndrome Revenue Market Share by Application, 2024 VS 2031
Figure 24. Respiratory Distress Syndrome Revenue Share by Company (2024)
Figure 25. Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Poractant Alfa Revenue Proportion by Company in 2024
Figure 27. Beractant Revenue Proportion by Company in 2024
Figure 28. Calfactant Revenue Proportion by Company in 2024
Figure 29. Others Revenue Proportion by Company in 2024
Figure 30. North America Respiratory Distress Syndrome Revenue 2020-2031 (US$ Million)
Figure 31. North America Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
Figure 32. North America Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
Figure 33. Asia-Pacific Respiratory Distress Syndrome Revenue 2020-2031 (US$ Million)
Figure 34. Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
Figure 37. Europe Respiratory Distress Syndrome Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Respiratory Distress Syndrome Revenue Market Share by Country (2020-2031)
Figure 39. Europe Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
Figure 40. Europe Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
Figure 41. Latin America Respiratory Distress Syndrome Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Respiratory Distress Syndrome Revenue Market Share by Country (2020-2031)
Figure 43. Latin America Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
Figure 44. Latin America Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
Figure 45. Middle East and Africa Respiratory Distress Syndrome Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
Figure 48. Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
Figure 49. Respiratory Distress Syndrome Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Respiratory Distress Syndrome Raw Materials by Region in 2024
Figure 51. Respiratory Distress Syndrome Distribution Channels
Figure 52. Global Respiratory Distress Syndrome Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 53. Global Respiratory Distress Syndrome Percentage 2020-2031: Online Sales VS Offline Sales
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Table 1. Global Respiratory Distress Syndrome Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Respiratory Distress Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Respiratory Distress Syndrome Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Respiratory Distress Syndrome Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Respiratory Distress Syndrome Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Respiratory Distress Syndrome Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Respiratory Distress Syndrome Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Respiratory Distress Syndrome Revenue by Company (2020-2025) & (US$ Million)
Table 11. Respiratory Distress Syndrome Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Respiratory Distress Syndrome Players by Revenue (US$ Million) in 2024
Table 13. Global Respiratory Distress Syndrome Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Respiratory Distress Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Distress Syndrome as of 2024)
Table 15. Global Respiratory Distress Syndrome Companies Headquarters
Table 16. Date of International Companies Enter into Respiratory Distress Syndrome Market
Table 17. Global Respiratory Distress Syndrome Companies Product & Service
Table 18. Global Respiratory Distress Syndrome Mergers & Acquisitions, Expansion Plans
Table 19. Chiesi Farmaceutici Corporation Information
Table 20. Chiesi Farmaceutici Description and Business Overview
Table 21. Chiesi Farmaceutici Respiratory Distress Syndrome Product
Table 22. Chiesi Farmaceutici Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Chiesi Farmaceutici Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
Table 24. Chiesi Farmaceutici Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
Table 25. Chiesi Farmaceutici Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
Table 26. Chiesi Farmaceutici Recent Developments
Table 27. CR-Double Crane Corporation Information
Table 28. CR-Double Crane Description and Business Overview
Table 29. CR-Double Crane Respiratory Distress Syndrome Product
Table 30. CR-Double Crane Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. CR-Double Crane Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
Table 32. CR-Double Crane Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
Table 33. CR-Double Crane Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
Table 34. CR-Double Crane Recent Developments
Table 35. ONY Biotech Corporation Information
Table 36. ONY Biotech Description and Business Overview
Table 37. ONY Biotech Respiratory Distress Syndrome Product
Table 38. ONY Biotech Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. ONY Biotech Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
Table 40. ONY Biotech Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
Table 41. ONY Biotech Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
Table 42. ONY Biotech Recent Developments
Table 43. AbbVie Corporation Information
Table 44. AbbVie Description and Business Overview
Table 45. AbbVie Respiratory Distress Syndrome Product
Table 46. AbbVie Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. AbbVie Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
Table 48. AbbVie Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
Table 49. AbbVie Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
Table 50. AbbVie Recent Developments
Table 51. Yuhan Corporation Corporation Information
Table 52. Yuhan Corporation Description and Business Overview
Table 53. Yuhan Corporation Respiratory Distress Syndrome Product
Table 54. Yuhan Corporation Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Yuhan Corporation Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
Table 56. Yuhan Corporation Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
Table 57. Yuhan Corporation Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
Table 58. Yuhan Corporation Recent Developments
Table 59. JW Pharmaceuticals Corporation Information
Table 60. JW Pharmaceuticals Description and Business Overview
Table 61. JW Pharmaceuticals Respiratory Distress Syndrome Product
Table 62. JW Pharmaceuticals Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. JW Pharmaceuticals Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
Table 64. JW Pharmaceuticals Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
Table 65. JW Pharmaceuticals Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
Table 66. JW Pharmaceuticals Recent Developments
Table 67. Noargen Corporation Information
Table 68. Noargen Description and Business Overview
Table 69. Noargen Respiratory Distress Syndrome Product
Table 70. Noargen Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Noargen Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
Table 72. Noargen Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
Table 73. Noargen Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
Table 74. Noargen Recent Developments
Table 75. North America Respiratory Distress Syndrome Revenue by Country (2020-2025) & (US$ Million)
Table 76. North America Respiratory Distress Syndrome Revenue by Country (2026-2031) & (US$ Million)
Table 77. North America Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
Table 78. North America Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
Table 79. Asia-Pacific Respiratory Distress Syndrome Revenue by Region (2020-2025) & (US$ Million)
Table 80. Asia-Pacific Respiratory Distress Syndrome Revenue by Region (2026-2031) & (US$ Million)
Table 81. Asia-Pacific Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
Table 82. Asia-Pacific Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
Table 83. Europe Respiratory Distress Syndrome Revenue by Country (2020-2025) & (US$ Million)
Table 84. Europe Respiratory Distress Syndrome Revenue by Country (2026-2031) & (US$ Million)
Table 85. Europe Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
Table 86. Europe Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
Table 87. Latin America Respiratory Distress Syndrome Revenue by Country (2020-2025) & (US$ Million)
Table 88. Latin America Respiratory Distress Syndrome Revenue by Country (2026-2031) & (US$ Million)
Table 89. Latin America Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
Table 90. Latin America Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
Table 91. Middle East and Africa Respiratory Distress Syndrome Revenue by Country (2020-2025) & (US$ Million)
Table 92. Middle East and Africa Respiratory Distress Syndrome Revenue by Country (2026-2031) & (US$ Million)
Table 93. Middle East and Africa Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
Table 94. Middle East and Africa Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
Table 95. Respiratory Distress Syndrome Key Raw Materials, Industry Status and Trend
Table 96. Respiratory Distress Syndrome Key Raw Materials and Upstream Suppliers
Table 97. Respiratory Distress Syndrome Clients Status and Trend
Table 98. Respiratory Distress Syndrome Typical Clients
Table 99. Respiratory Distress Syndrome Distributors
Table 100. Respiratory Distress Syndrome Market Trends
Table 101. Respiratory Distress Syndrome Market Drivers
Table 102. Respiratory Distress Syndrome Market Challenges
Table 103. Respiratory Distress Syndrome Market Restraints
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Respiratory Distress Syndrome Product Picture
Figure 2. Global Respiratory Distress Syndrome Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Respiratory Distress Syndrome Revenue Market Share by Type in 2024 & 2031
Figure 4. Poractant Alfa Product Picture
Figure 5. Beractant Product Picture
Figure 6. Calfactant Product Picture
Figure 7. Others Product Picture
Figure 8. Global Respiratory Distress Syndrome Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Respiratory Distress Syndrome Revenue Market Share by Application in 2024 & 2031
Figure 10. Very Preterm Infants
Figure 11. Moderate to Late Preterm Infants
Figure 12. Others
Figure 13. Respiratory Distress Syndrome Report Years Considered
Figure 14. Global Respiratory Distress Syndrome Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Respiratory Distress Syndrome Market Size (2020-2031) & (US$ Million)
Figure 16. Global Respiratory Distress Syndrome Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Respiratory Distress Syndrome Revenue Market Share by Region (2020-2031)
Figure 18. Global Respiratory Distress Syndrome Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Respiratory Distress Syndrome Revenue Market Share Forecast by Application (2020-2031)
Figure 20. Poractant Alfa of Respiratory Distress Syndrome Revenue Market Share by Application, 2024 VS 2031
Figure 21. Beractant of Respiratory Distress Syndrome Revenue Market Share by Application, 2024 VS 2031
Figure 22. Calfactant of Respiratory Distress Syndrome Revenue Market Share by Application, 2024 VS 2031
Figure 23. Others of Respiratory Distress Syndrome Revenue Market Share by Application, 2024 VS 2031
Figure 24. Respiratory Distress Syndrome Revenue Share by Company (2024)
Figure 25. Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Poractant Alfa Revenue Proportion by Company in 2024
Figure 27. Beractant Revenue Proportion by Company in 2024
Figure 28. Calfactant Revenue Proportion by Company in 2024
Figure 29. Others Revenue Proportion by Company in 2024
Figure 30. North America Respiratory Distress Syndrome Revenue 2020-2031 (US$ Million)
Figure 31. North America Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
Figure 32. North America Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
Figure 33. Asia-Pacific Respiratory Distress Syndrome Revenue 2020-2031 (US$ Million)
Figure 34. Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
Figure 37. Europe Respiratory Distress Syndrome Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Respiratory Distress Syndrome Revenue Market Share by Country (2020-2031)
Figure 39. Europe Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
Figure 40. Europe Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
Figure 41. Latin America Respiratory Distress Syndrome Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Respiratory Distress Syndrome Revenue Market Share by Country (2020-2031)
Figure 43. Latin America Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
Figure 44. Latin America Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
Figure 45. Middle East and Africa Respiratory Distress Syndrome Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
Figure 48. Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
Figure 49. Respiratory Distress Syndrome Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Respiratory Distress Syndrome Raw Materials by Region in 2024
Figure 51. Respiratory Distress Syndrome Distribution Channels
Figure 52. Global Respiratory Distress Syndrome Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 53. Global Respiratory Distress Syndrome Percentage 2020-2031: Online Sales VS Offline Sales
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232